Skip to content Home / Companies / COCH COC
Envoy Medical, Inc. (COCH) XNAS ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES Net insider buying (90d)
Latest COCH Insider Trades
About Envoy Medical, Inc. (COCH) Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Headquarters WHITE BEAR LAKE, MN
Employees 47
Listed 2023
Exchange XNAS https://www.envoymedical.com SEC filings for COCH on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Grant or award 3 2,250,000
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
COCH Insider Transactions (Form 4) 55 26 Form 4 filings on record, the earliest from Nov 21, 2024, newest first.
Date Insider Transaction Security Shares Price Value Aug 24, 2026 RP Robert Potashnick - Officer Grant or award Stock Option (right to buy) 250,000
Recent COCH Form 8-K Filings 5
COCH Insider Trading - FAQ
What is the latest insider trade for COCH? Envoy Medical, Inc. (COCH) had 2 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for COCH runs to 26 Form 4 filings, the earliest from 2024-11-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying COCH stock? No insider purchases of COCH were filed in the last 90 days. 21 purchases are on record for this company.
How many insiders are selling COCH stock? No insider sales of COCH were filed in the last 90 days.
Where can I see COCH SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks COCH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow COCH insider buys? Create a free InsiderAlpha account and press Watch on this page to add COCH to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track COCH insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free MP
Open-market purchase 312,500 sh
SK Susan Kantor - Director Open-market purchase $38K
Feb 12, 2026
SK Susan Kantor - Director Open-market purchase 57,690 sh
Feb 12, 2026
Market cap $52.64M
P/E ratio -
Dividend yield -
Average volume 360.6K
52 week high $1.89
52 week low $0.36
Today's high -
Today's low -
Open -
Volume -
Previous close $0.68
Shares outstanding 77.39M Market cap
$54.96M
47 employees
Most-Active COCH Insiders - Last 90 Days 10 Jun 19, 2026 BL Brent T. Lucas - Officer Grant or award Stock Option (right to buy) 1,000,000 $0.00 -
Jun 19, 2026 BL Brent T. Lucas - Officer Grant or award Restricted Stock Units 1,000,000 $0.00 -
May 29, 2026 BL Brent T. Lucas - Officer Grant or award Class A Common Stock 32,856 $0.60 $20K
Apr 15, 2026 CM Chas McKhann - Director Grant or award Stock Option (Right to Buy) 100,000 $0.00 -
Feb 12, 2026 MP Mona Chetan Patel - Director Open-market purchase Class A Common Stock 312,500 $0.40 $125K
Feb 12, 2026 MP Mona Chetan Patel - Director Open-market purchase Warrant (right to buy) 187,500 $0.00 -
Feb 12, 2026 MP Mona Chetan Patel - Director Open-market purchase Warrant (right to buy) 312,500 $0.00 -
Feb 12, 2026 RP Robert Potashnick - Officer Open-market purchase Class A Common Stock 212,500 $0.40 $85K
Feb 12, 2026 RP Robert Potashnick - Officer Open-market purchase Warrant (right to buy) 127,500 $0.00 -
Feb 12, 2026 RP Robert Potashnick - Officer Open-market purchase Warrant (right to buy) 212,500 $0.00 -
Feb 12, 2026 SK Susan Kantor - Director Open-market purchase Class A Common Stock 96,150 $0.40 $38K
Feb 12, 2026 SK Susan Kantor - Director Open-market purchase Warrant (right to buy) 57,690 $0.00 -
Feb 12, 2026 SK Susan Kantor - Director Open-market purchase Warrant (right to buy) 96,150 $0.00 -
Feb 12, 2026 CB Charles Brynelsen - Director Open-market purchase Class A Common Stock 1,000,000 $0.40 $400K
Feb 12, 2026 CB Charles Brynelsen - Director Open-market purchase Warrant (right to buy) 600,000 $0.00 -
Feb 12, 2026 CB Charles Brynelsen - Director Open-market purchase Warrant (right to buy) 1,000,000 $0.00 -
Feb 12, 2026 BL Brent T. Lucas - Officer Open-market purchase Class A Common Stock 62,500 $0.40 $25K
Feb 12, 2026 BL Brent T. Lucas - Officer Open-market purchase Warrant (right to buy) 37,500 $0.00 -
Feb 12, 2026 BL Brent T. Lucas - Officer Open-market purchase Warrant (right to buy) 62,500 $0.00 -
Feb 12, 2026 GT Glen A. Taylor - 10% Owner Open-market purchase Class A Common Stock 18,750,000 $0.40 $7.50M
Feb 12, 2026 GT Glen A. Taylor - 10% Owner Open-market purchase Warrant Shares (Series A-1) 11,250,000 $0.00 -
Feb 12, 2026 GT Glen A. Taylor - 10% Owner Open-market purchase Warrant Shares (Series A-2) 18,750,000 $0.00 -
Feb 5, 2026 RP Robert Potashnick - Officer Grant or award Stock Option (right to buy) 15,000 $0.00 -
Feb 5, 2026 BL Brent T. Lucas - Officer Grant or award Stock Option (right to buy) 200,000 $0.00 -
Dec 3, 2025 MP Mona Chetan Patel - Director Grant or award Stock Option (right to buy) 25,000 $0.00 -
Dec 3, 2025 JS Janis Smith-Gomez - Director Grant or award Stock Option (right to buy) 25,000 $0.00 -
Dec 3, 2025 SK Susan Kantor - Director Grant or award Stock Option (right to buy) 62,500 $0.00 -
Dec 3, 2025 CB Charles Brynelsen - Director Grant or award Stock Option (right to buy) 62,500 $0.00 -
Sep 4, 2025 GT Glen A. Taylor - Director Derivative Warrant (right to buy) 500,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 500,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Derivative Warrant (right to buy) 250,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 250,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Derivative Warrant (right to buy) 250,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 250,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Derivative Warrant (right to buy) 500,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 500,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Derivative Warrant (right to buy) 500,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 500,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Derivative Warrant (right to buy) 750,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 750,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Derivative Warrant (right to buy) 750,000 - -
Sep 4, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 750,000 - -
Jun 26, 2025 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 750,000 $0.00 -
Dec 23, 2024 SK Susan Kantor Other Class A Common Stock 34,705 $0.00 -
Dec 20, 2024 Anzu SPAC GP I LLC Other Class A Common Stock, par value $0.0001 per share 1,028,986 $0.00 -
Dec 23, 2024 Anzu SPAC GP I LLC Other Class A Common Stock, par value $0.0001 per share 2,028,986 $0.00 -
Dec 20, 2023 Anzu SPAC GP I LLC Other Series A Preferred Stock, par value $0.0001 per share 373,333 $0.00 -
Dec 11, 2024 GT Glen A. Taylor - Director Grant or award Warrant (right to buy) 500,000 $0.00 -
Dec 11, 2024 BL Brent T. Lucas - Officer Open-market purchase Warrant (right to buy) 94,293 $0.06 $5K
Dec 11, 2024 BL Brent T. Lucas - Officer Open-market purchase Warrant (right to buy) 16,694 $0.06 $1K
Nov 20, 2024 MP Mona Chetan Patel - Director Open-market purchase Class A Common Stock 2,500 $2.28 $6K
Nov 19, 2024 SK Susan Kantor - Director Other Class A Common Stock 18,182 $0.00 -
Nov 19, 2024 Anzu SPAC GP I LLC - 10% Owner Other Class A Common Stock, par value $0.0001 per share 1,000,000 $0.00 -
COY $STE
STERIS plc
